Immucor Message Board - Msg: 5230710

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mason Barge who wrote (112)	7/17/1998 1:27:00 PM
From: Thomas Kirwin	of 422

Immucor Public Relations Update Mason, et al Just spoke to Ms. Connie Vinson of Immucor's Corporate Communications Dept. (770) 441-2051 regarding recent PR steps taken in light of the ABS2000 FDA approval. Believe you me Immucor is spreading the word. Ms. Vinson indicated that 450+ Investor Information Kits have been mailed as of July 10th to various media, analysts and institutional investors. Immucor also produced an informational video that accompanies some kits when appropriate. Several analysts have expressed interest in Immucor's prospects as evidenced by visits to Immucor's Corporate Headquarters during the last two weeks. I did not ask which investment firms dropped by. It was enough for me to know that Immucor is indeed on the radar screen. While my conversation with Connie was short she was kind enough to release the list price of an ABS2000 which is $110,000. The actual price paid may vary as discounts have been accruing towards instrumentation purchases via a reagent point program offered to customers. Very interesting! Go Immucor! Regards, Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next